Immuno-OpenPET: a novel approach for early diagnosis and image-guided surgery for small resectable pancreatic cancer
Open Access
- 10 March 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-11
Abstract
Pancreatic cancer (PC) has a poor prognosis owing to difficulties in the diagnosis of resectable PC at early stages. Several clinical studies have indicated that the detection and surgery of small resectable PC (64Cu-labeled anti-epidermal growth factor receptor antibody cetuximab was intraperitoneally administered into mice. It clearly identified PC tumors ≥3 mm. In contrast, neither OpenPET with intravenous-administered 64Cu-cetuximab nor intraperitoneal/intravenous-administered 18F-FDG (a traditional PET probe) could detect PC in this model. Immuno-OpenPET-guided surgery accurately resected small PC in mice and achieved significantly prolonged survival. This technology could provide a novel diagnostic and therapeutic strategy for small resectable PC to improve patient survival.Keywords
Funding Information
- MEXT | Japan Society for the Promotion of Science (19H03609)
This publication has 30 references indexed in Scilit:
- Positron Emission Tomography: Current Challenges and Opportunities for Technological Advances in Clinical and Preclinical Imaging SystemsAnnual Review of Biomedical Engineering, 2015
- Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoformsScientific Reports, 2015
- Novel Therapeutics for Pancreatic AdenocarcinomaHematology/Oncology Clinics of North America, 2015
- A Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid ProfilePLOS ONE, 2015
- High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environmentBiomaterials, 2015
- Plasma Metabolite Biomarkers for the Detection of Pancreatic CancerJournal of Proteome Research, 2014
- PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibodyJournal for ImmunoTherapy of Cancer, 2013
- A single-ring OpenPET enabling PET imaging during radiotherapyPhysics in Medicine & Biology, 2012
- Epidermal Growth Factor Receptor in Pancreatic CancerCancers, 2011
- Clinicopathological Aspects of 542 Cases of Pancreatic Cancer: a Special Emphasis on Small Pancreatic CancerJournal of Korean Medical Science, 2007